- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 3.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.94 | - |
NAV | ₹21.78 | - |
Fund Started | 17 Aug 2018 | - |
Fund Size | ₹2902.18 Cr | - |
Exit Load | For units more than 12% of the investments, an exit load of 1% if redeemed within 12 months. | - |
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.94
-
NAV
₹21.78
-
Fund Started
17 Aug 2018
-
Fund Size
₹2902.18 Cr
-
Exit Load
For units more than 12% of the investments, an exit load of 1% if redeemed within 12 months.
-
Returns
1 Year | 7.28% | - |
3 Year | 8.94% | - |
5 Year | 13.92% | - |
1 Year
7.28%
-
3 Year
8.94%
-
5 Year
13.92%
-
Holding Analysis
Equity | 96.29% | - |
Cash | 3.71% | - |
Equity
96.29%
-
Cash
3.71%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
HDFC Bank Ltd. | 9.47% |
Reliance Industries Ltd. | 4.08% |
Kotak Mahindra Bank Ltd. | 3.69% |
Axis Bank Ltd. | 3.67% |
ICICI Bank Ltd. | 3.53% |
ITC Ltd. | 3.00% |
Maruti Suzuki India Ltd. | 2.99% |
Tata Consultancy Services Ltd. | 2.68% |
Piramal Pharma Ltd. | 2.61% |
Larsen & Toubro Ltd. | 2.49% |
-
Fund Manager
Name | Abhinav Sharma | - |
Start Date | 01 Nov 2019 | - |
Name
Abhinav Sharma
-
Start Date
01 Nov 2019
-
About Fund
Description | The Scheme aims to generate capital appreciation by investing in a diversified portfolio of equity & equity related instruments across market capitalization. The scheme will predominantly invest in equity and equity related instruments of well researched and growth oriented companies. | - |
Launch Date | 17 Aug 2018 | - |
Description
The Scheme aims to generate capital appreciation by investing in a diversified portfolio of equity & equity related instruments across market capitalization. The scheme will predominantly invest in equity and equity related instruments of well researched and growth oriented companies.
-
Launch Date
17 Aug 2018
-
